130 related articles for article (PubMed ID: 12469117)
1. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions.
Tesselaar K; Arens R; van Schijndel GM; Baars PA; van der Valk MA; Borst J; van Oers MH; van Lier RA
Nat Immunol; 2003 Jan; 4(1):49-54. PubMed ID: 12469117
[TBL] [Abstract][Full Text] [Related]
2. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency.
Ghosh S; Köstel Bal S; Edwards ESJ; Pillay B; Jiménez Heredia R; Erol Cipe F; Rao G; Salzer E; Zoghi S; Abolhassani H; Momen T; Gostick E; Price DA; Zhang Y; Oler AJ; Gonzaga-Jauregui C; Erman B; Metin A; Ilhan I; Haskologlu S; Islamoglu C; Baskin K; Ceylaner S; Yilmaz E; Unal E; Karakukcu M; Berghuis D; Cole T; Gupta AK; Hauck F; Kogler H; Hoepelman AIM; Baris S; Karakoc-Aydiner E; Ozen A; Kager L; Holzinger D; Paulussen M; Krüger R; Meisel R; Oommen PT; Morris E; Neven B; Worth A; van Montfrans J; Fraaij PLA; Choo S; Dogu F; Davies EG; Burns S; Dückers G; Becker RP; von Bernuth H; Latour S; Faraci M; Gattorno M; Su HC; Pan-Hammarström Q; Hammarström L; Lenardo MJ; Ma CS; Niehues T; Aghamohammadi A; Rezaei N; Ikinciogullari A; Tangye SG; Lankester AC; Boztug K
Blood; 2020 Dec; 136(23):2638-2655. PubMed ID: 32603431
[TBL] [Abstract][Full Text] [Related]
3. CD70-induced differentiation of proinflammatory Th1/17/22/GM lymphocytes associated with disease progression and immune reconstitution during HIV infection.
Wang X; Wei Y; He Z; Wang D; Zhang L; Du J; Zhang M; Jiang M; Chen N; Deng M; Li B; Song C; Chen D; Liu H; Xiao J; Liang H; Zhao H; Kong Y
Emerg Microbes Infect; 2023 Dec; 12(2):2271068. PubMed ID: 37824079
[TBL] [Abstract][Full Text] [Related]
4. CD27 and CD70 in T cell and B cell activation.
Borst J; Hendriks J; Xiao Y
Curr Opin Immunol; 2005 Jun; 17(3):275-81. PubMed ID: 15886117
[TBL] [Abstract][Full Text] [Related]
5. PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8
Buchan SL; Fallatah M; Thirdborough SM; Taraban VY; Rogel A; Thomas LJ; Penfold CA; He LZ; Curran MA; Keler T; Al-Shamkhani A
Clin Cancer Res; 2018 May; 24(10):2383-2394. PubMed ID: 29514845
[No Abstract] [Full Text] [Related]
6. GENCODE reference annotation for the human and mouse genomes.
Frankish A; Diekhans M; Ferreira AM; Johnson R; Jungreis I; Loveland J; Mudge JM; Sisu C; Wright J; Armstrong J; Barnes I; Berry A; Bignell A; Carbonell Sala S; Chrast J; Cunningham F; Di Domenico T; Donaldson S; Fiddes IT; García Girón C; Gonzalez JM; Grego T; Hardy M; Hourlier T; Hunt T; Izuogu OG; Lagarde J; Martin FJ; Martínez L; Mohanan S; Muir P; Navarro FCP; Parker A; Pei B; Pozo F; Ruffier M; Schmitt BM; Stapleton E; Suner MM; Sycheva I; Uszczynska-Ratajczak B; Xu J; Yates A; Zerbino D; Zhang Y; Aken B; Choudhary JS; Gerstein M; Guigó R; Hubbard TJP; Kellis M; Paten B; Reymond A; Tress ML; Flicek P
Nucleic Acids Res; 2019 Jan; 47(D1):D766-D773. PubMed ID: 30357393
[TBL] [Abstract][Full Text] [Related]
7. Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks.
Jaeger-Ruckstuhl CA; Lo Y; Fulton E; Waltner OG; Shabaneh TB; Simon S; Muthuraman PV; Correnti CE; Newsom OJ; Engstrom IA; Kanaan SB; Bhise SS; Peralta JMC; Ruff R; Price JP; Stull SM; Stevens AR; Bugos G; Kluesner MG; Voillet V; Muhunthan V; Morrish F; Olson JM; Gottardo R; Sarthy JF; Henikoff S; Sullivan LB; Furlan SN; Riddell SR
Immunity; 2024 Feb; 57(2):287-302.e12. PubMed ID: 38354704
[TBL] [Abstract][Full Text] [Related]
8. Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy.
Geng Q; Jiao P
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257366
[TBL] [Abstract][Full Text] [Related]
9. Delayed vaccine-induced CD8
van der Sluis TC; van Haften FJ; van Duikeren S; Pardieck IN; de Graaf JF; Vleeshouwers W; van der Maaden K; Melief CJM; van der Burg SH; Arens R
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030302
[TBL] [Abstract][Full Text] [Related]
10. Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.
Kaulen LD; Denisova E; Hinz F; Hai L; Friedel D; Henegariu O; Hoffmann DC; Ito J; Kourtesakis A; Lehnert P; Doubrovinskaia S; Karschnia P; von Baumgarten L; Kessler T; Baehring JM; Brors B; Sahm F; Wick W
Acta Neuropathol; 2023 Sep; 146(3):499-514. PubMed ID: 37495858
[TBL] [Abstract][Full Text] [Related]
11. Checkpoint Inhibitors in Acute Myeloid Leukemia.
Damiani D; Tiribelli M
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371818
[TBL] [Abstract][Full Text] [Related]
12. Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer.
Ding S; Qiao N; Zhu Q; Tong Y; Wang S; Chen X; Tian Q; Xiao Y; Shen K
Cancer Commun (Lond); 2023 Jun; 43(6):661-684. PubMed ID: 37158690
[TBL] [Abstract][Full Text] [Related]
13. Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy.
Sadeghirad H; Liu N; Monkman J; Ma N; Cheikh BB; Jhaveri N; Tan CW; Warkiani ME; Adams MN; Nguyen Q; Ladwa R; Braubach O; O'Byrne K; Davis M; Hughes BGM; Kulasinghe A
Front Immunol; 2023; 14():1135489. PubMed ID: 37153589
[TBL] [Abstract][Full Text] [Related]
14. Chronic CD27-CD70 costimulation promotes type 1-specific polarization of effector Tregs.
Bowakim-Anta N; Acolty V; Azouz A; Yagita H; Leo O; Goriely S; Oldenhove G; Moser M
Front Immunol; 2023; 14():1023064. PubMed ID: 36993956
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in Mice.
Stephan AS; Kosinska AD; Mück-Häusl M; Muschaweckh A; Jäger C; Röder N; Heikenwälder M; Dembek C; Protzer U
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851121
[TBL] [Abstract][Full Text] [Related]
16. Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy.
Guelen L; Fischmann TO; Wong J; Mauze S; Guadagnoli M; Bąbała N; Wagenaars J; Juan V; Rosen D; Prosise W; Habraken M; Lodewijks I; Gu D; Stammen-Vogelzangs J; Yu Y; Baker J; Lutje Hulsik D; Driessen-Engels L; Malashock D; Kreijtz J; Bertens A; de Vries E; Bovens A; Bramer A; Zhang Y; Wnek R; Troth S; Chartash E; Dobrenkov K; Sadekova S; van Elsas A; Cheung JK; Fayadat-Dilman L; Borst J; Beebe AM; Van Eenennaam H
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36100308
[TBL] [Abstract][Full Text] [Related]
17. Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors.
Sanborn RE; Pishvaian MJ; Callahan MK; Weise A; Sikic BI; Rahma O; Cho DC; Rizvi NA; Sznol M; Lutzky J; Bauman JE; Bitting RL; Starodub A; Jimeno A; Reardon DA; Kaley T; Iwamoto F; Baehring JM; Subramaniam DS; Aragon-Ching JB; Hawthorne TR; Rawls T; Yellin M; Keler T
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35940825
[TBL] [Abstract][Full Text] [Related]
18. Identification of an Immune Gene-Based Cisplatin Response Model and CD27 as a Therapeutic Target against Cisplatin Resistance for Ovarian Cancer.
Guo Y; Yang N; Li G; Yin X; Dong L
J Immunol Res; 2022; 2022():4379216. PubMed ID: 35647204
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients.
Li C; Liu F; Sun L; Liu Z; Zeng Y
BMC Cancer; 2022 Mar; 22(1):230. PubMed ID: 35236310
[TBL] [Abstract][Full Text] [Related]
20. Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc).
Aschmoneit N; Kocher K; Siegemund M; Lutz MS; Kühl L; Seifert O; Kontermann RE
Oncoimmunology; 2022; 11(1):2028961. PubMed ID: 35083097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
